| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ab6c040066603ef2519d512b21dce9ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4fafa5d0ac7350a2b310a7ac1f5b2792 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-556
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-585
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-401
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-401
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-341
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-585 |
| filingDate |
1999-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2664c008384b6205128b83943ce8fb6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bfc2319b03057066e26bf9670228a9b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e48c9981c859ebf2f325d4ee7c7ca176
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df580135696dc4815a0414617d05bf8a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f8c9619a34319a24af1e6f126090fdb |
| publicationDate |
2003-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EA-003782-B1 |
| titleOfInvention |
COMBINED THERAPY WITH THE USE OF ANGIOTENZIN CONVERSION AND ANTAGONIST ALDOSTERONE ENVIRONMENTAL INHIBITOR TO REDUCE THE DISEASE AND MORTALITY WITH CARDIOVASCULAR DISEASES |
| abstract |
The combinations of FAA inhibitor, aldosterone antagonist and loop diuretic for use in the treatment of circulatory disorders are described. Of particular interest are therapies using captopril, enalapril or lisinopril in conjunction with spironolactone. This combination therapy may be particularly useful for reducing mortality or non-fatal hospitalization or to prevent the progression of congestive heart failure in patients with cardiovascular diseases. |
| priorityDate |
1998-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |